ArticleAdvances in experimental medicine and biology2026
Mapping the Proteomes of Bacteriophages E215 and LUZ19 Using Liquid Chromatography Tandem Mass Spectrometry.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance is a global public health concern, and the World Health Organization has identified extensively-drug-resistant Pseudomonas aeruginosa as an urgent threat. The emergence of such pathogens has severely restricted the scope of therapeutic options for clinicians, and has reignited interest in the use of bacteriophage therapy to treat extensively-drug-resistant pathogens. Bacteriophages are viruses which infect and replicate in bacterial hosts, and lytic phages can kill host bacterial cells. Here, we adapted a bottom-up proteomics method used in serum proteomics for mapping the proteomes of two phages which have shown the ability to infect and destroy P. aeruginosa, E215 and LUZ19. This method employed surfactant-aided digestion/on-pellet digestion (SOD) with sodium dodecyl sulfate to denature the phage particles and form protein pellets; these pellets were subjected to disulfide reduction and alkylation, followed by trypsin digestion. The resulting mixtures were separated using a gradient LC approach and analyzed by high-resolution tandem mass spectrometry. For E215, 23 proteins, including ten previously hypothetical proteins from genomic sequencing, were identified. For LUZ19, only four proteins, including two hypothetic proteins from genomics, were identified. However, for both E215 and LUZ19, tryptic peptides from the major head protein of each phage were identified, including one candidate surrogate peptide from each phage to be explored in future quantification studies by LC-MS/MS. These results illustrate that surfactant-aided digestion/on-pellet digestion is an effective approach for proteomic investigations of bacteriophages.
Indexed as
Identifiers
42907635What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.